location: Current position: Shijun Zhong @ Computational Chemistry Lab >> Scientific Research >> Paper Publications

How Y357F, Y276F mutants affect the methylation activity of PRDM9: QM/MM MD and free energy simulations

Hits:

Indexed by:Journal Papers

Date of Publication:2015-05-01

Journal:JOURNAL OF MOLECULAR MODELING

Included Journals:SCIE、PubMed、Scopus

Volume:21

Issue:5

Page Number:125

ISSN No.:1610-2940

Key Words:Catalytic activity; Histone methyltransferase; Methylation activity; QM/MM MD and free energy simulations; Reactive complex

Abstract:Histone methyltransferase PRDM9 catalyzes the methylation of H3K4me2 (histone 3 dimethylated lysine 4) to H3K4me3 (histone 3 trimethylated lysine 4) by transferring the methyl group from S-adenosyl methionine (AdoMet). PRDM9 is the major determinant of the meiotic recombination hotspot and the enrichment of H3K4me3 at the hotspot defines the initiation site of meiotic recombination. In PRDM9, two conserved tyrosine residues Tyr357 and Tyr276 surrounding the amino group of the substrate lysine may influence the methylation activity through hydrogen bond interactions with AdoMet or the substrate lysine. In this study, quantum mechanical/molecular mechanical (QM/MM) molecular dynamics (MD) and free energy simulations were performed to reveal the methylation processes catalyzed by wild type PRDM9, its Y357F, and Y276F mutants, respectively. The different roles of Tyr357 and Tyr276 in the methylation activity of PRDM9 were also investigated and compared. The calculated free energy barriers of the methyl transfers suggest that the Y276F mutation decreases the catalytic activity of the methyl transfer, while the Y357F mutation does not change the catalytic activity of the methyl transfer. The reactant complex conformations generated in the QM/MM MD simulations show that the reactive configuration can be formed in the Y357F mutant but not in the Y276F mutant.

Pre One:Novel Cathelicidins from Pigeon Highlights Evolutionary Convergence in Avain Cathelicidins and Functions in Modulation of Innate Immunity

Next One:A Novel GTP-Binding Inhibitor, FX2149, Attenuates LRRK2 Toxicity in Parkinson's Disease Models